Targeting mitochondria by ss-31 ameliorates the whole body energy status in cancer- and chemotherapy-induced cachexia

HIGHLIGHTS

• who: Riccardo Ballarò and collaborators from the Department of Clinical and Biological Sciences, University of Torino, Torino, Italy have published the research: Targeting Mitochondria by SS-31 Ameliorates the Whole Body Energy Status in Cancer- and Chemotherapy-Induced Cachexia, in the Journal: (JOURNAL) of 20/01/2021
• what: This study aimed at evaluating the ability of the mitochondria-targeted compound SS-31 to counteract muscle wasting and altered metabolism in C26-bearing (C26) mice either receiving chemotherapy (OXFU: oxaliplatin plus 5-fluorouracil) or not. The contribution of oxidative stress to cancer cachexia can be considered . . .
  

   

  

  If you want to have access to all the content you need to log in!

  Thanks :)

  Username or E-mail:

  If you don't have an account, you can create one here.